Clinical Trials on Combinational Immunotherapy

Total 301 results

Peking Union Medical College Hospital

Completed

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Cholangiocarcinoma | Biomarker | Combinational Immunotherapy | Liver Neoplasm Malignant Primary

China
Zhang Bi Xiang, MD

Recruiting

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma (CCGLC-003)

Hyperbaric Oxygen Therapy | Combinational Immunotherapy | Hepatocellular Carcinoma Non-Resectable

China
Ajou University School of Medicine

Completed

Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG

Immunotherapy

Korea, Republic of
University of Oxford
Mahidol University; Mahidol Oxford Tropical Medicine Research Unit

Terminated

Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects (ALAQPQ)

Healthy | Pharmacokinetic | Drug Combination

Thailand
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

Immunotherapy

China
Centre Georges Francois Leclerc
AstraZeneca

Active, not recruiting

Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment (GUIDE2REPAIR)

Immunotherapy

France
Anhui Provincial Hospital

Unknown

NK Cells Infusion for Advanced Malignancies

Immunotherapy

China
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Zagazig University

Completed

Triple Antigen vs Monoantigen Immunotherapy for Warts

Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts

Egypt
Xuanwu Hospital, Beijing

Recruiting

A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy

Immunotherapy | ADR

China
University of Oxford
Mahidol University; Mahidol Oxford Tropical Medicine Research Unit

Recruiting

Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects (ALAQ)

Healthy | Pharmacokinetic | Drug Combination

Thailand
Rutgers, The State University of New Jersey
Pfizer; American Cancer Society, Inc.

Completed

Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy (PINPOINT)

Immunotherapy | Clinical Trials

United States
Peking University First Hospital
YiZhou International Cancer Hospital

Unknown

Combination of Hypofractionated Proton Therapy With Immunotherapy (I-HypoPT)

Immunotherapy | Proton Therapy
Nanfang Hospital, Southern Medical University

Recruiting

Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

Immunotherapy | Biomarker | Hyperprogression

China
Peking University First Hospital

Not yet recruiting

Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors

Immunotherapy | SBRT | Bulky Tumor
University of Erlangen-Nürnberg Medical School
Wuerzburg University Hospital; University Hospital Regensburg

Recruiting

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy (PROMIT)

Immunotherapy

Germany
Hoffmann-La Roche

Completed

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

Drug Therapy, Combination

United Kingdom
National Taiwan University Hospital

Active, not recruiting

Patient Care Needs and the Decision-Making Experience of Patients With Cancer and Family Caregivers Regarding Immunotherapy: A Qualitative and Quantitative Mixed Methods Study

Immunotherapy | Supportive Care Needs

Taiwan
University of Oxford
Mahidol University; Mahidol Oxford Tropical Medicine Research Unit

Completed

Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects

Healthy | Pharmacokinetics | Drug Combination

Thailand
Xinqiao Hospital of Chongqing

Recruiting

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Artificial Intelligence | Malignant Tumor | Immunotherapy

China
Valérie LAURENT

Completed

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

Advanced HCC Treated by Systemic Immunotherapy

France
University Health Network, Toronto

Active, not recruiting

Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

Advanced Cancer | Immunotherapy | Radiation Therapy | Palliative

Canada
Cairo University

Enrolling by invitation

Combination of Spinal-Epidural With General Anesthesia in Patients Undergoing Mega-Liposuction Surgery

Combination of General Anesthesia to Spinal and Epidural Techniques

Egypt
University of Helsinki
Social Insurance Institution, Finland; City of Lohja, Services for Aged People and other collaborators

Completed

Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care

Polypharmacy | Inappropriate Prescribing | Drug Therapy, Combination

Finland
Ankara Medipol University

Recruiting

The Effect of Education and Telephone Follow-up Given to Cancer Patients Receiving Immunotherapy on Symptom Management and Self-care Power

Self Care | Immunotherapy | Symptom Management | Cancer Patient

Turkey
Centre Francois Baclesse

Completed

Study of the Cognition of Patients Treated With Immunotherapy (COG-IMMUNO)

Patients With Cancer Who Start Immunotherapy | All Neoplasms

France
Second Affiliated Hospital of Guangzhou Medical...
Hunan Zhaotai Yongren Medical Innovation Co. Ltd.

Recruiting

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Anti-cancer Cell Immunotherapy | T Cell and NK Cell

China
Michael Scharl

Recruiting

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Cancer | Immunotherapy | Immune Checkpoint Inhibitors | Fecal Microbiota Transplantation

Switzerland
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment (Ibe2i-TIPCI)

Immunotherapy | Immune Checkpoint Inhibitors | Immune-related Adverse Event | Predictive Biomarkers

France
Kafkas University

Completed

Effect of Z Technıque on Pain, Comfort, Symptoms in Ummunotherapy Areas

Immunotherapy

Turkey
Hellenic Cooperative Oncology Group

Completed

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (CIAD)

Autoimmune Diseases | Immunotherapy | Checkpoint Inhibitor

Greece
The University Clinic of Pulmonary and Allergic...

Unknown

Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

Allergy | Immunotherapy | Omalizumab | Bee Venom

Slovenia
Bristol-Myers Squibb

Completed

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients (SPARTAN)

HIV, Combination Therapy

France, Germany, Spain, United States, Italy, Poland, United Kingdom
Nanfang Hospital of Southern Medical University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (PANORAMA)

Chemotherapy | Immunotherapy

China
Viome
AdventHealth

Recruiting

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Gynecologic Cancer | Immunotherapy | Gut Microbiome

United States
West China Hospital

Recruiting

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Immunotherapy | SBRT | Stage IV HCC

China
Mahidol University

Active, not recruiting

Immunological Response After Shrimp Oral Immunotherapy Treatment

Immunotherapy | Allergy to Shrimp

Thailand
Chuangzhen Chen

Recruiting

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors (ILDRV1)

Radiotherapy | Immune Checkpoint Blockade | Metastatic Extracranial Malignant Solid Neoplasm | Resistance to Immunotherapy

China
Johann Wolfgang Goethe University Hospital
Allergopharma GmbH & Co. KG

Completed

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

Immunotherapy

Germany
Guangdong Association of Clinical Trials

Recruiting

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Lung Cancer | Immunotherapy

China
Nemours Children's Clinic

Completed

Evaluation of Pain Alleviating Strategies During Allergy Shots (PPAST)

Allergy | Immunotherapy

United States
Vanda Pharmaceuticals

Completed

Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol

Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol

Canada
Mahidol University

Recruiting

Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy

Immunotherapy | Wheat Hypersensitivity

Thailand
University Hospital, Montpellier

Completed

Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice (CHOICE)

Allergen Immunotherapy

France
Jiangsu HengRui Medicine Co., Ltd.

Completed

Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia

Used to Induce and Implement General Anesthesia in Combination With Sedative Anesthetics (Such as Propofol)

China
Shanghai Juncell Therapeutics
Sir Run Run Shaw Hospital

Recruiting

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Advanced Solid Tumor | Treatment Side Effects | Effects of Immunotherapy | Tumor Infiltrating Lymphocytes

China
Baodong Qin

Unknown

Effect of Chemotherapy on PD-L1 in NSCLC

Chemotherapy | Immunotherapy | PD-L1

China
University Hospital, Grenoble
Jules Bordet Institute

Completed

Cancer Patients Treated With Immunotherapy in Intensive Care Unit (IMMUNO-REA)

Cancer | Critical Illness | Immunotherapy

Belgium, France
Shanghai International Medical Center

Unknown

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Chemotherapy | Advanced Malignancies | Precision Cell Immunotherapy

China
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands

Clinical Trials on Combinational Immunotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations